Published in N Engl J Med on December 03, 2009
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Changing the future of obesity: science, policy, and action. Lancet (2011) 5.56
Obesity and cancer. Oncologist (2010) 3.01
Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med (2013) 2.59
Measuring Recent Apparent Declines In Longevity: The Role Of Increasing Educational Attainment. Health Aff (Millwood) (2015) 2.09
The unique authority of state and local health departments to address obesity. Am J Public Health (2011) 1.83
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Effects of obesity and smoking on U.S. life expectancy. N Engl J Med (2010) 1.67
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) (2011) 1.48
Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care (2010) 1.39
Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study. Am J Epidemiol (2014) 1.37
New forecasting methodology indicates more disease and earlier mortality ahead for today's younger Americans. Health Aff (Millwood) (2011) 1.34
Simulation models of obesity: a review of the literature and implications for research and policy. Obes Rev (2010) 1.31
Childhood obesity and environmental chemicals. Mt Sinai J Med (2011) 1.31
Secular declines in the association between obesity and mortality in the United States. Popul Dev Rev (2011) 1.22
Rising educational gradients in mortality: the role of behavioral risk factors. J Health Econ (2011) 1.18
Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab (2011) 1.14
Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet (2010) 1.12
Genetic link between obesity and MMP14-dependent adipogenic collagen turnover. Diabetes (2010) 1.11
Race, place, and obesity: the complex relationships among community racial/ethnic composition, individual race/ethnicity, and obesity in the United States. Am J Public Health (2012) 1.10
Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J Environ Public Health (2012) 1.08
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch (2010) 1.04
The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol (2013) 1.03
Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol (2012) 1.01
More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Aff (Millwood) (2013) 1.01
An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol (2010) 1.00
Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J Biol Chem (2010) 0.99
Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res (2014) 0.99
Projecting the effect of changes in smoking and obesity on future life expectancy in the United States. Demography (2014) 0.99
Determining energy expenditure from treadmill walking using hip-worn inertial sensors: an experimental study. IEEE Trans Biomed Eng (2011) 0.98
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol (2014) 0.98
Obesity in Older Adults: Epidemiology and Implications for Disability and Disease. Rev Clin Gerontol (2012) 0.96
Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol (2012) 0.96
Childhood obesity: a life-long health risk. Acta Pharmacol Sin (2012) 0.93
Quality-adjusted life expectancy (QALE) loss due to smoking in the United States. Qual Life Res (2012) 0.91
Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Braz J Med Biol Res (2012) 0.91
US trends in quality-adjusted life expectancy from 1987 to 2008: combining national surveys to more broadly track the health of the nation. Am J Public Health (2013) 0.91
Setting population targets for measuring successful obesity prevention. Am J Public Health (2010) 0.90
Prepregnancy body mass index, smoking during pregnancy, and infant birth weight. Ann Epidemiol (2011) 0.90
Should I stay or should I go? Understanding families' decisions regarding initiating, continuing, and terminating health services for managing pediatric obesity: the protocol for a multi-center, qualitative study. BMC Health Serv Res (2012) 0.89
Colorectal cancer screening among primary care patients: does risk affect screening behavior? J Community Health (2011) 0.89
Obesity and trends in life expectancy. J Obes (2012) 0.89
The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis Model Mech (2013) 0.88
Decomposing Indigenous life expectancy gap by risk factors: a life table analysis. Popul Health Metr (2013) 0.87
The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy. Value Health (2012) 0.87
Estimating benefits of past, current, and future reductions in smoking rates using a comprehensive model with competing causes of death. Prev Chronic Dis (2012) 0.86
Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology. Cell Mol Life Sci (2012) 0.85
Cognitive decline and the default American lifestyle. J Gerontol B Psychol Sci Soc Sci (2011) 0.85
Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes. Sci Rep (2016) 0.85
Quantifying policy options for reducing future coronary heart disease mortality in England: a modelling study. PLoS One (2013) 0.84
An eicosanoid-centric view of atherothrombotic risk factors. Cell Mol Life Sci (2012) 0.84
Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry (2012) 0.84
Forecast of future premature mortality as a result of trends in obesity and smoking: nationwide cohort simulation study. Eur J Epidemiol (2010) 0.84
Obesity, sympathetic overdrive, and hypertension: the leptin connection. Hypertension (2010) 0.83
Public health in a time of government austerity. Am J Public Health (2012) 0.83
Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation. Dig Dis Sci (2015) 0.82
Health inequity in access to bariatric surgery: a protocol for a systematic review. Syst Rev (2014) 0.81
Changes in body weight and food choice in those attempting smoking cessation: a cluster randomised controlled trial. BMC Public Health (2012) 0.81
Laminin α4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain. PLoS One (2014) 0.81
Teachable moments for health behavior change and intermediate patient outcomes. Patient Educ Couns (2014) 0.81
Estimating the Effects of Obesity and Weight Change on Mortality Using a Dynamic Causal Model. PLoS One (2015) 0.81
Derivation of background mortality by smoking and obesity in cancer simulation models. Med Decis Making (2012) 0.80
The use of low-calorie sweeteners by children: implications for weight management. J Nutr (2012) 0.80
Susceptibility variants for waist size in relation to abdominal, visceral, and hepatic adiposity in postmenopausal women. J Acad Nutr Diet (2012) 0.79
Tobacco and the escalating global cancer burden. J Oncol (2011) 0.79
Simulating the impact of changing trends in smoking and obesity on productivity of an industrial population: an observational study. BMJ Open (2014) 0.79
NEIGHBORHOOD PERCEPTION AND OBESITY IN AGED MEXICAN AMERICANS. J Frailty Aging (2012) 0.79
Obesity and Black Women: Special Considerations Related to Genesis and Therapeutic Approaches. Curr Cardiovasc Risk Rep (2013) 0.79
Obesity and cancer, a case for insulin signaling. Cell Death Dis (2015) 0.79
The net effect of smoking on healthcare and welfare costs. A cohort study. BMJ Open (2012) 0.79
Co-occurring obesity and smoking among U.S. women of reproductive age: Associations with educational attainment and health biomarkers and outcomes. Prev Med (2015) 0.79
The Body Mass Index-Mortality Link across the Life Course: Two Selection Biases and Their Effects. PLoS One (2016) 0.78
Nicotine, food intake, and activation of POMC neurons. Neuropsychopharmacology (2013) 0.78
BMI and obesity in US blood donors: a potential public health role for the blood centre. Public Health Nutr (2012) 0.78
Obesity, lifestyle risk-factors, and health service outcomes among healthy middle-aged adults in Canada. BMC Health Serv Res (2012) 0.78
Effects of Crude Oil/Dispersant Mixture and Dispersant Components on PPARγ Activity in Vitro and in Vivo: Identification of Dioctyl Sodium Sulfosuccinate (DOSS; CAS #577-11-7) as a Probable Obesogen. Environ Health Perspect (2015) 0.78
Predictors of clinical outcome after tracheotomy in critically ill obese patients. Laryngoscope (2014) 0.78
The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol (2017) 0.77
Adolescent BMI at Northern Israel: From Trends, to Associated Variables and Comorbidities, and to Medical Signatures. Medicine (Baltimore) (2016) 0.77
Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. J Hypertens (2014) 0.77
Association of body mass index and waist circumference with successful aging. Obesity (Silver Spring) (2013) 0.77
Body mass index, smoking, and risk of death between 40 and 70 years of age in a Norwegian cohort of 32,727 women and 33,475 men. Eur J Epidemiol (2013) 0.77
Cost-Effectiveness of Fiscal Policies to Prevent Obesity. Curr Obes Rep (2013) 0.76
Obese Smokers as a Potential Subpopulation of Risk in Tobacco Reduction Policy. Yale J Biol Med (2015) 0.76
Examining the nature of the association between attention-deficit hyperactivity disorder and nicotine dependence: a familial risk analysis. Can J Psychiatry (2013) 0.76
Strategic plan of the Canadian Institutes of Health Research Institute of Nutrition, Metabolism, and Diabetes. Can J Gastroenterol (2011) 0.75
Carcinogenic effects of oil dispersants: A KEGG pathway-based RNA-seq study of human airway epithelial cells. Gene (2016) 0.75
Nature appropriation and associations with population health in Canada's largest cities. Int J Environ Res Public Health (2013) 0.75
Trends in body mass index among Icelandic adolescents and young adults from 1992 to 2007. Int J Environ Res Public Health (2010) 0.75
Health and the Economy in the United States, from 1750 to the Present. J Econ Lit (2015) 0.75
How to get a smoker addicted to quitting. Neth Heart J (2016) 0.75
Obesity vaccines. Hum Vaccin Immunother (2013) 0.75
Population-Based Estimates of Decreases in Quality-Adjusted Life Expectancy Associated with Unhealthy Body Mass Index. Public Health Rep (2016) 0.75
Potential health gains and health losses in eleven EU countries attainable through feasible prevalences of the life-style related risk factors alcohol, BMI, and smoking: a quantitative health impact assessment. BMC Public Health (2016) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Actual causes of death in the United States, 2000. JAMA (2004) 44.38
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
A potential decline in life expectancy in the United States in the 21st century. N Engl J Med (2005) 19.63
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
The epidemiology of obesity. Gastroenterology (2007) 8.35
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) (2008) 7.40
Financial incentive-based approaches for weight loss: a randomized trial. JAMA (2008) 7.01
Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86
The epidemiology of obesity: the size of the problem. J Intern Med (2008) 3.62
Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ (2008) 3.58
Correction: actual causes of death in the United States, 2000. JAMA (2005) 3.30
Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity (Silver Spring) (2006) 3.04
United States life tables, 2004. Natl Vital Stat Rep (2007) 3.03
The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) (2005) 2.85
Why is the developed world obese? Annu Rev Public Health (2008) 2.64
Forecasting the obesity epidemic in the aging U.S. population. Obesity (Silver Spring) (2007) 2.09
Health and economic implications of a tobacco-free society. JAMA (1987) 1.86
The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) (2005) 1.79
A clinical blueprint to accelerate the elimination of tobacco use. JAMA (2008) 1.72
The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers. Prev Med (1999) 1.68
Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med (2008) 1.61
Body mass index and quality of well-being in a community of older adults. Am J Prev Med (2004) 1.46
The mortality risk of smoking and obesity combined. Am J Prev Med (2006) 1.37
The transition to post-industrial BMI values among US children. Am J Hum Biol (2009) 1.35
Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr (2006) 1.34
The effects of changes in smoking prevalence on obesity prevalence in the United States. Am J Public Health (2007) 1.34
Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract (2004) 1.15
The impact of symptoms and impairments on overall health in US national health data. Med Care (2008) 1.11
Obesity prevention: the role of policies, laws and regulations. Aust New Zealand Health Policy (2008) 1.11
The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach. Pharmacoeconomics (2005) 0.98
Weight-associated deaths in the United States. J Womens Health (Larchmt) (2007) 0.94
Predicted impact of attaining smoking reduction goals on mortality. South Med J (2001) 0.92
Views of practicing physicians and the public on medical errors. N Engl J Med (2002) 7.15
Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) (2008) 6.13
Incidence and mortality of hip fractures in the United States. JAMA (2009) 6.05
The value of medical spending in the United States, 1960-2000. N Engl J Med (2006) 5.38
The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000. Health Aff (Millwood) (2008) 4.94
Medicare and cost-effectiveness analysis. N Engl J Med (2005) 4.20
Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement (2008) 4.00
Value-based insurance design. Health Aff (Millwood) (2007) 3.27
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med (2005) 2.60
Bias in published cost effectiveness studies: systematic review. BMJ (2006) 2.60
Increased spending on health care: how much can the United States afford? Health Aff (Millwood) (2003) 2.41
Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood) (2008) 2.37
Mortality reduction among pneumonia patients still substantial despite the impact of coding changes. Am J Med (2013) 2.14
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care (2010) 2.05
Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82
Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis. BMJ (2004) 1.77
Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann Intern Med (2007) 1.65
Increasing health insurance costs and the decline in insurance coverage. Health Serv Res (2005) 1.61
Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ (2007) 1.60
Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med (2008) 1.56
Challenges in building disease-based national health accounts. Med Care (2009) 1.50
Pain management in nursing home residents with cancer. J Am Geriatr Soc (2015) 1.49
Trends in the measurement of health utilities in published cost-utility analyses. Value Health (2006) 1.47
Growth and quality of the cost-utility literature, 1976-2001. Value Health (2005) 1.42
Trends in medical spending by age, 1963-2000. Health Aff (Millwood) (2004) 1.42
Comparison of trends in US health-related quality of life over the 2000s using the SF-6D, HALex, EQ-5D, and EQ-5D visual analog scale versus a broader set of symptoms and impairments. Med Care (2014) 1.41
Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37
Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med (2011) 1.36
Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34
Disability and the future of Medicare. N Engl J Med (2003) 1.32
Increased spending on health care: long-term implications for the nation. Health Aff (Millwood) (2009) 1.23
Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg Am (2005) 1.22
Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthop Relat Res (2007) 1.22
Cost-utility analysis studies of depression management: a systematic review. Am J Psychiatry (2004) 1.21
Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med (2010) 1.19
The ACO rules--striking the balance between participation and transformative potential. N Engl J Med (2011) 1.18
Evidence that value-based insurance can be effective. Health Aff (Millwood) (2010) 1.17
The impact of symptoms and impairments on overall health in US national health data. Med Care (2008) 1.11
A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006. Med Decis Making (2010) 1.08
The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer (2007) 1.04
Psychological distress and trends in healthcare expenditures and outpatient healthcare. Am J Manag Care (2011) 1.03
Girls' education and HIV risk: evidence from Uganda. J Health Econ (2013) 1.01
Can we better prioritize resources for cost-utility research? Med Decis Making (2005) 0.99
Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) (2009) 0.93
US trends in quality-adjusted life expectancy from 1987 to 2008: combining national surveys to more broadly track the health of the nation. Am J Public Health (2013) 0.91
Overuse of antidepressants in a nationally representative adult patient population in 2005. Psychiatr Serv (2011) 0.88
The value of coronary heart disease care for the elderly: 1987-2002. Health Aff (Millwood) (2007) 0.88
Disability forecasts and future Medicare costs. Front Health Policy Res (2004) 0.88
Rising out-of-pocket costs in disease management programs. Am J Manag Care (2006) 0.87
Medical spending differences in the United States and Canada: the role of prices, procedures, and administrative expenses. Inquiry (2010) 0.84
Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005. Med Care (2010) 0.84
A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis (2005) 0.84
Diffusion of published cost-utility analyses in the field of health policy and practice. Int J Technol Assess Health Care (2005) 0.83
Grounding coverage in value: a paradigm for linking quality and costs. Med Care (2006) 0.82
Ultraviolet index and racial differences in prostate cancer incidence and mortality. Cancer (2013) 0.82
A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci (2009) 0.81
Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes. Health Aff (Millwood) (2013) 0.80
Do drug formulary policies reflect evidence of value? Am J Manag Care (2006) 0.79
Potential consequences of reforming Medicare into a competitive bidding system. JAMA (2012) 0.78
The 'graying' of group health insurance. Health Aff (Millwood) (2006) 0.78
Health care in the next administration. N Engl J Med (2008) 0.78
Why health reform will bend the cost curve. Issue Brief (Commonw Fund) (2009) 0.78
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol (2004) 0.78
The reply. Am J Med (2013) 0.75
Recent national trends in acute myocardial infarction hospitalizations in Medicare: shrinking declines and growing disparities. Epidemiology (2015) 0.75
Short-term Outcomes for Medicare Beneficiaries After Low-acuity Visits to Emergency Departments and Clinics. Med Care (2016) 0.75
Cost savings associated with expanded hospice use in Medicare. J Palliat Med (2015) 0.75
Confronting hysteria: a reply to Fairman and Curtiss. J Manag Care Pharm (2008) 0.75
Efficiencies, jobs, and staying the course. Interview by John Marcille. Manag Care (2013) 0.75
Enhancing Administrative Data to Predict Emergency Department Utilization: The Role of Neighborhood Sociodemographics. J Health Care Poor Underserved (2017) 0.75
Health insurance and the American public sector labor market. J Health Econ (2014) 0.75
Potential impact of Affordable Care Act-related insurance expansion on trauma care reimbursement. J Trauma Acute Care Surg (2017) 0.75